1-2 of 2
Huilai Zhang, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study

Yuqin Song, MD PhD, Quanli Gao, MD, Huilai Zhang, PhD, Lei Fan, MD PhD, Jianfeng Zhou, PhD, Dehui Zou, MD, Wei Li, MD, Haiyan Yang, PhD, Ting Liu, MD, Quanshun Wang, MD PhD, Fangfang Lv, MD, Yu Yang, MD, Haiyi Guo, MD, Liudi Yang, MD, Rebecca Elstrom, MD, Jane Huang, MD, William Novotny, MD, Vivian Wei, PhD, Jun Zhu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 682.
https://doi.org/10.1182/blood-2018-99-117848
Published: 2018
Journal Articles

Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial

Yuqin Song, MD PhD, Keshu Zhou, MD, Dehui Zou, MD, Jianfeng Zhou, PhD, Jianda Hu, PhD, Haiyan Yang, PhD, Huilai Zhang, PhD, Jie Ji, MD, Wei Xu, MD PhD, Jie Jin, MD PhD, Fangfang Lv, MD, Ru Feng, MD, Sujun Gao, PhD, Daobin Zhou, MD, Haiyi Guo, MD, Aihua Wang, PhD, James Hilger, PhD, Jane Huang, MD, William Novotny, MD, Muhtar Osman, PhD, Jun Zhu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 148.
https://doi.org/10.1182/blood-2018-99-117956
Published: 2018